528
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis, molecular docking, molecular dynamics and evaluation of Drug-Likeness properties of the fused N-Formyl pyrazoline substituted new dehydroepiandrosterone derivatives

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2492-2503 | Received 30 May 2021, Accepted 21 Jan 2022, Published online: 08 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (3)

Gökay Çetiner, Ulviye Acar Çevik, Ismail Celik, Hayrani Eren Bostancı, Yusuf Özkay & Zafer Asım Kaplancıklı. (2023) New imidazole derivatives as aromatase inhibitor: Design, synthesis, biological activity, molecular docking, and computational ADME-Tox studies. Journal of Molecular Structure 1278, pages 134920.
Crossref
Jin-Bu Xu, Jin Bi, Peng Wen, Shi-Xing Miao, Xiao-Huan Li & Feng Gao. (2023) Synthesis and Cytotoxicity Evaluation of Dehydroepiandrosterone Derivatives by Iron-catalyzed Stereoselective Hydroamination. Chemical and Pharmaceutical Bulletin.
Crossref
Serena Vittorio, Candida Manelfi, Silvia Gervasoni, Andrea R. Beccari, Alessandro Pedretti, Giulio Vistoli & Carmine Talarico. (2022) Computational Insights into the Sequence-Activity Relationships of the NGF(1–14) Peptide by Molecular Dynamics Simulations. Cells 11:18, pages 2808.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.